Advarra Acquires Quorum Review IRB and Kinetiq

March 6, 2019

Applied Clinical Trials

Advarra, provider of institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services in North America, announced the acquisition of Quorum, one of the central IRBs in the U.S. and Canada. The transaction also includes Quorum’s research and technology consulting division, Kinetiq.

Read the full release here.

 

Related Content:

News